UCB Renews Agreement for Genedata's Phylosopher and Expressionist Platforms | GenomeWeb
NEW YORK (GenomeWeb News) —Genedata said today that UCB has renewed and expanded an agreement to use two Genedata software platforms in its lead discovery research.
 
The new agreement will allow UCB to use Genedata's Phylosopher and Expressionist software in its biologics and lead-finding studies for central nervous system disorders and autoimmune and inflammatory disorders that are conducted in the UK and Belgium.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.